OLATUTON

This brand name is authorized in Ireland, Malta, UK.

Active ingredients

The drug OLATUTON contains one active pharmaceutical ingredient (API):

1	Octreotide UNII 75R0U2568I - OCTREOTIDE ACETATE
	Octreotide is a synthetic octapeptide derivative of naturally occurring somatostatin with similar pharmacological effects, but with a considerably prolonged duration of action. It inhibits pathologically increased secretion of growth hormone (GH) and of peptides and serotonin produced within the GEP endocrine system.
	Read more about Octreotide

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
OLATUTON Powder and solvent for suspension for injection	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
H01CB02	Octreotide	H Systemic hormonal preparations, excl. Sex hormones and insulins → H01 Pituitary and hypothalamic hormones and analogues → H01C Hypothalamic hormones → H01CB Somatostatin and analogues
Discover more medicines within H01CB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
GB	Medicines & Healthcare Products Regulatory Agency	378469, 378473, 378475
MT	Medicines Authority	AA565/62801, AA565/62802